On January 13th, it was reported that the 250,000 tons/year cyclohexane dehydrogenation unit (Phase I) of Guangxi Hengyi's 1.2 million tons/year caprolactam-polyamide integrated and supporting project, which utilizes technology and catalysts provided by China National Chemical Engineering Research Institute, was designed by Saiding Company and constructed by Sanhuajian, has successfully completed its first feed-in operation. The entire process has been smoothly integrated, and qualified products have been continuously produced with stable unit operation. Chempricehub's analysis of caprolactam, with a long-short score of -2: The successful commissioning of Guangxi Hengyi's 1.2 million tons/year caprolactam unit, achieving full-process integration and continuous production of qualified products, significantly increases market supply. The increase in supply is expected to alleviate supply-demand tightness, putting downward pressure on spot prices, thus rated as a significant bearish factor. Benzene, with a long-short score of 2: Following the commissioning of the new unit, demand for benzene, a key raw material in caprolactam production, is expected to rise. This increase in demand may drive up spot prices. Additionally, based on benzene futures market data, recent contracts such as 2603 closed at 5,584 yuan/ton (up 21 yuan) and 2604 closed at 5,638 yuan/ton (up 31 yuan), indicating strong upward momentum in the market. The rising demand will further support the upward trend in futures prices, thus rated as a significant bullish factor.